Zhu Limei, Wang Ran, Zhang Li, Zuo Chunlei, Zhang Rui, Zhao Shaolin
Department of Clinical Laboratory, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China,
Onco Targets Ther. 2019 Jan 3;12:405-412. doi: 10.2147/OTT.S180935. eCollection 2019.
Previous research indicated that overexpression of miRNA-211 could promote colorectal cancer cell growth by targeting tumor suppressive gene Chromodomain-helicase-DNA-binding protein 5 (CHD5) in human colon cancer (CC). Moreover, the function of the single-nucleotide polymorphism (SNP) located in the mature region of miR-211 has not been investigated. In this study, we found that SNP of rs187960998 in miR-211 was involved in the occurrence of CC by acting as a tumor suppressor by mal-regulation of its target gene .
The genotype of total 685 CC patients was detected by real-time PCR, the proliferation of CC cell lines with different genotypes of miR-211 was determined by Cell Counting Kit-8, cell invasion evaluated by transwell and the activity of the CHD5 promoter in CC cell lines transfected with different miR-211 was determined by luciferase assay. The expression of CHD5 in CC patients was determined by the immunohistochemistry, and the relapse-free survival rate was analyzed by Kaplan-Meier analysis.
C/T SNP of miR-211 could inhibit CC cell proliferation and invasion by upregulation of CHD5. And SNP in rs187960998 of miR-211 was associated with tumor size, metastasis and tumor differentiation in CC patients. Patients with CC genotype have significantly low CHD5 expression than the T-carrier, while no significant expression difference in miR-211 expression among different genotype subsets. Patients with CC genotype have significantly shorter postsurgery survival rate compared to the T-carrier.
rs187960998 in miR-211 was highly associated with a decreased risk of CC in the Chinese population by deregulating a tumor suppressive gene CHD5.
先前的研究表明,在人类结肠癌(CC)中,miRNA - 211的过表达可通过靶向肿瘤抑制基因染色质结构域解旋酶DNA结合蛋白5(CHD5)促进结肠癌细胞生长。此外,位于miR - 211成熟区域的单核苷酸多态性(SNP)的功能尚未得到研究。在本研究中,我们发现miR - 211中rs187960998的SNP通过对其靶基因的调控异常而作为一种肿瘤抑制因子参与CC的发生。
采用实时荧光定量PCR检测685例CC患者的基因型,使用细胞计数试剂盒 - 8测定不同miR - 211基因型的CC细胞系的增殖情况,通过Transwell实验评估细胞侵袭能力,并通过荧光素酶报告基因检测法测定用不同miR - 211转染的CC细胞系中CHD5启动子的活性。采用免疫组织化学法测定CC患者中CHD5的表达,并通过Kaplan - Meier分析评估无复发生存率。
miR - 211的C/T SNP可通过上调CHD5抑制CC细胞增殖和侵袭。并且miR - 211的rs187960998中的SNP与CC患者的肿瘤大小、转移及肿瘤分化相关。CC基因型患者的CHD5表达明显低于T等位基因携带者,而不同基因型亚组之间miR - 211表达无明显差异。与T等位基因携带者相比,CC基因型患者术后生存率明显缩短。
miR - 211中的rs187960998通过调控肿瘤抑制基因CHD5与中国人群中CC风险降低高度相关。